BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15194129)

  • 1. Macrolide resistance phenotypes of commensal viridans group streptococci and Gemella spp. and PCR detection of resistance genes.
    Cerdá Zolezzi P; Rubio Calvo MC; Millán L; Goñi P; Canales M; Capilla S; Durán E; Gómez-Lus R
    Int J Antimicrob Agents; 2004 Jun; 23(6):582-9. PubMed ID: 15194129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of resistance to macrolides and other antibiotics in commensal viridans group streptococci and Gemella spp. and transfer of resistance genes to Streptococcus pneumoniae.
    Cerdá Zolezzi P; Laplana LM; Calvo CR; Cepero PG; Erazo MC; Gómez-Lus R
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3462-7. PubMed ID: 15328112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of tetracycline resistance genes tet(M), tet(O), tet(L) and tet(K) in blood isolates of viridans group streptococci harbouring erm(B) and mef(A) genes. Susceptibility to quinupristin/dalfopristin and linezolid.
    Rodriguez-Avial I; Rodriguez-Avial C; Culebras E; Picazo JJ
    Int J Antimicrob Agents; 2003 Jun; 21(6):536-41. PubMed ID: 12791466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolide resistance mechanisms and in vitro susceptibility patterns of viridans group streptococci isolated from blood cultures.
    Ergin A; Ercis S; Hasçelik G
    J Antimicrob Chemother; 2006 Jan; 57(1):139-41. PubMed ID: 16291867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of macrolide-lincosamide-streptogramin B (MLS(B)) and telithromycin resistance in clinical strains of staphylococci].
    Saribaş Z; Tunçkanat F; Ozçakir O; Ercis S
    Mikrobiyol Bul; 2010 Apr; 44(2):177-86. PubMed ID: 20549951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea.
    Uh Y; Shin DH; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
    J Antimicrob Chemother; 2004 Jun; 53(6):1095-7. PubMed ID: 15117924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phenotypes and genetic mechanisms of resistance to macrolides and lincosamides in viridans group streptococci].
    Artiles Campelo F; Horcajada Herrera I; Alamo Antúnez I; Cãnas Pedrosa A; Lafarga Capuz B
    Rev Esp Quimioter; 2007 Sep; 20(3):317-22. PubMed ID: 18080028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oropharyngeal carriage of macrolide-resistant viridans group streptococci: a prevalence study among healthy adults in Belgium.
    Malhotra-Kumar S; Lammens C; Martel A; Mallentjer C; Chapelle S; Verhoeven J; Wijdooghe M; Haesebrouck F; Goossens H
    J Antimicrob Chemother; 2004 Feb; 53(2):271-6. PubMed ID: 14729750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of telithromycin, quinupristin/dalfopristin, linezolid and comparator antimicrobial agents against Staphylococcus aureus clinical isolates.
    Millán L; Cerdá P; Rubio MC; Goñi P; Canales M; Capilla S; Oca M; Gómez-Lus R
    J Chemother; 2004 Jun; 16(3):230-7. PubMed ID: 15330317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora.
    Seppälä H; Haanperä M; Al-Juhaish M; Järvinen H; Jalava J; Huovinen P
    J Antimicrob Chemother; 2003 Oct; 52(4):636-44. PubMed ID: 12972451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Macrolide resistance phenotypes and genotypes in group G streptococci].
    Açikgöz ZC; Göçer S; Almayanlar E
    Mikrobiyol Bul; 2003; 37(2-3):117-24. PubMed ID: 14593892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
    Tazumi A; Maeda Y; Goldsmith CE; Coulter WA; Mason C; Millar BC; McCalmont M; Rendall J; Elborn JS; Matsuda M; Moore JE
    J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of telithromycin against viridans group streptococci and Streptococcus bovis isolated from blood: antimicrobial susceptibility patterns in different groups of species.
    Rodríguez-Avial I; Rodríguez-Avial C; Culebras E; Picazo JJ
    Antimicrob Agents Chemother; 2005 Feb; 49(2):820-3. PubMed ID: 15673778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors.
    Bemer-Melchior P; Juvin ME; Tassin S; Bryskier A; Schito GC; Drugeon HB
    Antimicrob Agents Chemother; 2000 Nov; 44(11):2999-3002. PubMed ID: 11036012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phenotypes of macrolide, lincosamide, and streptogramin resistant Streptococcus viridans isolated from blood].
    Rodríguez-Avial C; García MM; Rodríguez-Avial I; Picazo JJ
    Rev Esp Quimioter; 1999 Dec; 12(4):346-51. PubMed ID: 10855014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study.
    Mazzariol A; Koncan R; Bahar G; Cornaglia G
    J Chemother; 2007 Oct; 19(5):500-7. PubMed ID: 18073148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrolide-lincosamide-streptogramin B resistance phenotypes in clinical staphylococcal isolates.
    Cetin ES; Gunes H; Kaya S; Aridogan BC; Demirci M
    Int J Antimicrob Agents; 2008 Apr; 31(4):364-8. PubMed ID: 18206352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and characterization of the mechanisms of macrolide, lincosamide and streptogramin resistance in viridans group streptococci.
    Ioannidou S; Papaparaskevas J; Tassios PT; Foustoukou M; Legakis NJ; Vatopoulos AC
    Int J Antimicrob Agents; 2003 Dec; 22(6):626-9. PubMed ID: 14659663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to macrolides, lincosamides, streptogramins, and linezolid among members of the Staphylococcus sciuri group.
    Stepanović S; Martel A; Dakić I; Decostere A; Vuković D; Ranin L; Devriese LA; Haesebrouck F
    Microb Drug Resist; 2006; 12(2):115-20. PubMed ID: 16922627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.